Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of aliskiren vs amlodipine in hypertensive patients with abdominal obesity
2005-004566-16Phase 2Terminated
- Sponsor
- Novartis
- Start
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of aliskiren and amlodipine in hypertension (HTN) (2 arms), sponsored by Novartis. Primary endpoint: Pharmacodynamic assessment of aliskiren, amlodipine and RAS biomarkers. Started Feb 2007; status: terminated.
02
Drugs
aliskirenamlodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on 2005-004566-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004566-16.